Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.
Press releases published on April 14, 2025
Obatala Sciences and Ainnocence Announce Partnership to Transform Drug Discovery Through AI and Human Biological Models
EIN Presswire
·
April 14, 2025
MOUNTAIN VIEW, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Highlights: • Obatala Sciences and Ainnocence’s groundbreaking partnership addresses the FDA’s recent call for human-relevant methods for new drug development. • The partnership …
Elimu Informatics Joins AMIA as a Silver Corporate Partner to Advance Health Informatics Innovation
EIN Presswire
·
April 14, 2025
Elimu partners with AMIA as a Silver Corporate Partner, reinforcing its commitment to smarter data, better care, and health IT collaboration. EL CERRITO, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Elimu Informatics is proud to announce its …
Retina Eye UK Launches Dedicated Eye Screening and Diabetic Retinopathy Packages to Support Early Detection
EIN Presswire
·
April 14, 2025
Ms Sharon Heng has launched comprehensive eye screening and diabetic retinopathy packages aimed at improving early detection of diabetic eye disease. LONDON, LONDON, UNITED KINGDOM, April 15, 2025 /EINPresswire.com/ -- Ms Sharon Heng ,MBBS, PhD, …
Fluoropolymers Recently Diversified at Alfa Chemistry: FEP, PFA, PEEK Are Added
EIN Presswire
·
April 14, 2025
The chemical supplier Alfa Chemistry has expanded its fluoropolymer range to incorporate FEP, Perfluoroalkoxy Alkane (PFA), and Polyetheretherketone (PEEK). NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The chemical supplier Alfa Chemistry …
Blossom Family Medicine Partners with OpenDNA to Bring Precision Genetic Testing to Primary Care
EIN Presswire
·
April 14, 2025
ARLINGTON HEIGHTS, IL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Blossom Family Medicine is proud to announce a strategic collaboration with OpenDNA, a leader in precision medicine and AI-powered genetic analysis. This partnership brings …
The Brookbush Institute Publishes NEW Updates: 'Glossary: Stretch Shortening Cycle, Course: Power Training'
EIN Presswire
·
April 14, 2025
The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Excerpt from the course: Power (High-velocity) …
Sterling Lexicon's Redesigned Website Enhances User Experience, Showcases Talent Mobility Expertise
EIN Presswire
·
April 14, 2025
New features emphasize flexible solutions to meet changing workforce mobility priorities JACKSONVILLE, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Sterling Lexicon, a global leader in workforce mobility solutions, is proud to unveil its …
.ART ANNOUNCES 2024 AND 2025 KASIMOV ART THERAPY FELLOWSHIP RECIPIENTS
EIN Presswire
·
April 14, 2025
WASHINGTON, DC, DC, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- In celebration of the upcoming World Art Day, .ART Registry is proud to announce the 2025 recipients of the Kasimov Art Therapy Fellowship—an award established to support the next …
Quantum Utility Will be Achieved Within A Decade, According to Majority of Industry Professionals
EIN Presswire
·
April 14, 2025
Quantum professionals are overwhelmingly optimistic that quantum utility will be achieved within the next decade, research from Economist Impact today reveals. LONDON, UNITED KINGDOM, April 14, 2025 /EINPresswire.com/ -- 83% believe it will be reached …
Houston Patent Agent Offers Nonprovisional Patent Filing Services for Startups
EIN Presswire
·
April 14, 2025
Affordable Patent Agency expands to Houston, offering flat-fee nonprovisional patent filing services with expert support from a registered patent agent. HOUSTON, TX, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Affordable Patent Agency is excited …
SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)
GlobeNewswire
·
April 14, 2025
DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced that …